Two independent clinical trials demonstrate the safety of stem cell therapies for Parkinson's disease. The papers, published in Nature this week, investigate the use of cells derived from human induced pluripotent stem cells and human embryonic stem cells, respectively. However, further research is needed to test the effectiveness and clinical benefits of these therapies.
Parkinson's disease is a neurodegenerative disease characterized by the progressive loss of neurons that produce dopamine, a neurotransmitter. Although current treatments, such as ʟ-dopa, can alleviate symptoms in the early stages, their efficacy declines and they are often accompanied by side effects such as dyskinesia (involuntary movements). Cell therapy, specifically replenishing dopamine-producing (dopaminergic) neurons in the brain, could provide a potentially more effective treatment with fewer adverse effects.
View full article: https://medicalxpress.com/news/2025-04-stem-cell-therapy-potentially-safe.html
Source from medicalxpress.com
FIRSTCELL @ PAVILLION EMBASSY
Level 13A, Tower B, Kompleks Pavilion,
200 Jalan Ampang,
50450 Wilayah Persekutuan,
Kuala Lumpur, Malaysia.
Phone: +6016 328 9005
Email: info@firstcell.com.my